SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr | ₹9.62 Cr |
What is the latest Consolidated Net Profit of SAKAR HEALTHCARE ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹962,285 Cr |
Mar2020 | ₹9.62 Cr |
How is Consolidated Net Profit of SAKAR HEALTHCARE Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | -15.95 | |
Mar2023 | ₹15 Cr | 42.09 | |
Mar2022 | ₹11 Cr | -100.00 | |
Mar2021 | ₹962,285 Cr | 9,999,739.14 | |
Mar2020 | ₹9.62 Cr | - |
Compare Consolidated Net Profit of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹698.3 Cr | 0.5% | 1.3% | -3.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | 0.5% |
1.3% |
-3.8% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses